STOCK TITAN

Ten percent owner Jorey Chernett boosts Neuronetics (STIM) stake with 385K-share buy

Filing Impact
(Moderate)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Neuronetics, Inc. ten percent owner Jorey Chernett reported an open-market purchase of 385,442 shares of common stock at a weighted average price of $1.25 per share. After this transaction, Chernett directly beneficially owned 9,778,988 shares of Neuronetics common stock.

The shares were acquired in multiple trades at prices ranging from $1.23 to $1.26 per share, calculated on a weighted average basis. The filing also corrects a prior clerical error, noting that the previously reported beneficial ownership had been understated by 270 shares.

Positive

  • None.

Negative

  • None.
Insider Chernett Jorey
Role 10% Owner
Bought 385,442 shs ($482K)
Type Security Shares Price Value
Purchase Common Stock 385,442 $1.25 $482K
Holdings After Transaction: Common Stock — 9,778,988 shares (Direct)
Footnotes (1)
  1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.26, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased. This amount corrects a clerical error in the Reporting Person's Form 4 previously filed on March 30, 2026, in which the number of shares beneficially owned by the Reporting Person was under-reported by 270 shares.
Shares purchased 385,442 shares Open-market purchase of Neuronetics common stock
Weighted average price $1.25 per share Average price for 385,442 purchased shares
Post-transaction holdings 9,778,988 shares Total common shares beneficially owned directly after purchase
Price range of trades $1.23–$1.26 per share Range for multiple transactions included in the weighted average
Ownership correction 270 shares Previously under-reported beneficial ownership now corrected
Net buy shares 385,442 shares Net change from reported transactions (net-buy direction)
weighted average price financial
"The price reported in Column 4 is a weighted average price, rounded to the nearest cent."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned financial
"the number of shares beneficially owned by the Reporting Person was under-reported by 270 shares."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
ten percent owner financial
""is_ten_percent_owner": 1"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chernett Jorey

(Last)(First)(Middle)
6222 INDIANWOOD TR.

(Street)
BLOOMFIELD HILLS MICHIGAN 48301

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/30/2026P385,442A$1.25(1)9,778,988(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.23 to $1.26, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
2. This amount corrects a clerical error in the Reporting Person's Form 4 previously filed on March 30, 2026, in which the number of shares beneficially owned by the Reporting Person was under-reported by 270 shares.
/s/ Jorey Chernett03/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Jorey Chernett do in the latest Form 4 for STIM?

Jorey Chernett reported an open-market purchase of 385,442 shares of Neuronetics common stock. The weighted average purchase price was $1.25 per share, reflecting multiple trades executed between $1.23 and $1.26, and increased Chernett’s directly owned stake.

How many Neuronetics (STIM) shares does Jorey Chernett now own?

Following the reported transaction, Jorey Chernett beneficially owned 9,778,988 shares of Neuronetics common stock directly. This total incorporates the 385,442 shares purchased in the open market and includes a correction of 270 shares previously under-reported.

What price did Jorey Chernett pay for Neuronetics (STIM) shares?

The filing shows a weighted average purchase price of $1.25 per Neuronetics share. Actual trades occurred in multiple transactions at prices ranging from $1.23 to $1.26 per share, with the reported figure rounded to the nearest cent.

What does the clerical error correction mean in the STIM Form 4?

The Form 4 states that a previous filing under-reported Jorey Chernett’s beneficial ownership by 270 shares. This update corrects that clerical error so the current total of 9,778,988 shares accurately reflects Chernett’s directly owned Neuronetics position.

Is Jorey Chernett considered a major shareholder of Neuronetics (STIM)?

Yes. The Form 4 identifies Jorey Chernett as a ten percent owner of Neuronetics. This status means Chernett holds at least 10% of the company’s equity, and related trades must be reported to the SEC on ownership forms like this.
Neuronetics

NASDAQ:STIM

View STIM Stock Overview

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

89.37M
27.90M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN